At FAST, it’s our job to push forward all promising Angelman syndrome (AS) programs, and to ensure that the community has a birds-eye view of the entire landscape. Many of these programs are funded by FAST. The progress made is truly promising.
FAST provides a comprehensive, regularly updated overview of all therapeutic approaches in development for Angelman syndrome, from gene therapy and paternal gene activation to downstream pathway treatments, showing the full global pipeline of research progressing toward effective therapies.

At FAST, it’s our job to push forward all promising Angelman syndrome (AS) programs, and to ensure that the community has a birds-eye view of the entire landscape. Many of these programs are funded by FAST. The progress made is truly promising.